Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi

bloomberg

·

Original Report

↗ bloomberg

Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.